Literature DB >> 19098441

Anti-bovine prion protein RNA aptamer containing tandem GGA repeat interacts both with recombinant bovine prion protein and its beta isoform with high affinity.

Kazuyoshi Murakami1, Fumiko Nishikawa, Ken Noda, Takashi Yokoyama, Satoshi Nishikawa.   

Abstract

In order to obtain RNA aptamers against bovine prion protein (bPrP), we carried out in vitro selection from RNA pools containing a 55-nucleotide randomized region to target recombinant bPrP. Most of obtained aptamers contained conserved GGA tandem repeats (GGA)(4) and aptamer #1 (apt #1) showed a high affinity for both bPrP and its beta isoform (bPrP-beta). The sequence of apt #1 suggested that it would have a G-quadruplex structure, which was confirmed using CD spectra in titration with KCl. A mutagenic study of this conserved region, and competitive assays, showed that the conserved (GGA)(4) sequence is important for specific binding to bPrP and bPrP-beta. Following 5'-biotinylation, aptamer #1 specifically detected PrP(c) in bovine brain homogenate in a Northwestern blotting assay. Protein deletion mutant analysis showed that the bPrP aptamer binds within 25-131 of the bPrP sequence. Interestingly, the minimized aptamer #1 (17 nt) showed greater binding to bPrP and bPrP-beta as compared to apt #1. This minimized form of aptamer #1 may therefore be useful in the detection of bPrP, diagnosis of prion disease, enrichment of bPr and ultimately in gaining a better understanding of prion diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19098441      PMCID: PMC2634522          DOI: 10.4161/pri.2.2.7024

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  42 in total

1.  RNA aptamers specifically interact with the prion protein PrP.

Authors:  S Weiss; D Proske; M Neumann; M H Groschup; H A Kretzschmar; M Famulok; E L Winnacker
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state.

Authors:  B Caughey; G J Raymond; D Ernst; R E Race
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

3.  Interaction of prion peptide HuPrP106-126 with nucleic acid.

Authors:  P K Nandi
Journal:  Arch Virol       Date:  1997       Impact factor: 2.574

4.  Structure-function correlations of the insulin-linked polymorphic region.

Authors:  P Catasti; X Chen; R K Moyzis; E M Bradbury; G Gupta
Journal:  J Mol Biol       Date:  1996-12-06       Impact factor: 5.469

5.  Direct random mutagenesis of gene-sized DNA fragments using polymerase chain reaction.

Authors:  M Fromant; S Blanquet; P Plateau
Journal:  Anal Biochem       Date:  1995-01-01       Impact factor: 3.365

6.  The high-resolution crystal structure of a parallel-stranded guanine tetraplex.

Authors:  G Laughlan; A I Murchie; D G Norman; M H Moore; P C Moody; D M Lilley; B Luisi
Journal:  Science       Date:  1994-07-22       Impact factor: 47.728

7.  NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231).

Authors:  R Riek; S Hornemann; G Wider; R Glockshuber; K Wüthrich
Journal:  FEBS Lett       Date:  1997-08-18       Impact factor: 4.124

8.  Nucleic acid and prion protein interaction produces spherical amyloids which can function in vivo as coats of spongiform encephalopathy agent.

Authors:  P K Nandi; J-C Nicole
Journal:  J Mol Biol       Date:  2004-11-26       Impact factor: 5.469

9.  Application of a novel in vitro selection technique to isolate and characterise high affinity DNA aptamers binding mammalian prion proteins.

Authors:  David F Bibby; Andrew C Gill; Louise Kirby; Christine F Farquhar; Moira E Bruce; Jeremy A Garson
Journal:  J Virol Methods       Date:  2008-04-23       Impact factor: 2.014

Review 10.  Prions.

Authors:  S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

View more
  17 in total

1.  Selection of aptamers for amyloid beta-protein, the causative agent of Alzheimer's disease.

Authors:  Farid Rahimi; Gal Bitan
Journal:  J Vis Exp       Date:  2010-05-13       Impact factor: 1.355

Review 2.  Therapeutic development of polymers for prion disease.

Authors:  Kenta Teruya; Katsumi Doh-Ura
Journal:  Cell Tissue Res       Date:  2022-03-21       Impact factor: 5.249

3.  Binding of an RNA aptamer and a partial peptide of a prion protein: crucial importance of water entropy in molecular recognition.

Authors:  Tomohiko Hayashi; Hiraku Oshima; Tsukasa Mashima; Takashi Nagata; Masato Katahira; Masahiro Kinoshita
Journal:  Nucleic Acids Res       Date:  2014-05-06       Impact factor: 16.971

4.  d(GGGT) 4 and r(GGGU) 4 are both HIV-1 inhibitors and interleukin-6 receptor aptamers.

Authors:  Eileen Magbanua; Tijana Zivkovic; Björn Hansen; Niklas Beschorner; Cindy Meyer; Inken Lorenzen; Joachim Grötzinger; Joachim Hauber; Andrew E Torda; Günter Mayer; Stefan Rose-John; Ulrich Hahn
Journal:  RNA Biol       Date:  2012-12-12       Impact factor: 4.652

Review 5.  Role of MicroRNAs, Aptamers in Neuroinflammation and Neurodegenerative Disorders.

Authors:  Islauddin Khan; Kumari Preeti; Valencia Fernandes; Dharmendra Kumar Khatri; Shashi Bala Singh
Journal:  Cell Mol Neurobiol       Date:  2021-05-01       Impact factor: 4.231

6.  Unique quadruplex structure and interaction of an RNA aptamer against bovine prion protein.

Authors:  Tsukasa Mashima; Akimasa Matsugami; Fumiko Nishikawa; Satoshi Nishikawa; Masato Katahira
Journal:  Nucleic Acids Res       Date:  2009-08-07       Impact factor: 16.971

7.  RNA aptamers generated against oligomeric Abeta40 recognize common amyloid aptatopes with low specificity but high sensitivity.

Authors:  Farid Rahimi; Kazuma Murakami; Jamie L Summers; Chi-Hong B Chen; Gal Bitan
Journal:  PLoS One       Date:  2009-11-10       Impact factor: 3.240

8.  Cross-talk between prion protein and quadruplex-forming nucleic acids: a dynamic complex formation.

Authors:  Paola Cavaliere; Bruno Pagano; Vincenzo Granata; Stephanie Prigent; Human Rezaei; Concetta Giancola; Adriana Zagari
Journal:  Nucleic Acids Res       Date:  2012-10-27       Impact factor: 16.971

9.  Anti-prion activity of an RNA aptamer and its structural basis.

Authors:  Tsukasa Mashima; Fumiko Nishikawa; Yuji O Kamatari; Hiromichi Fujiwara; Masayuki Saimura; Takashi Nagata; Tsutomu Kodaki; Satoshi Nishikawa; Kazuo Kuwata; Masato Katahira
Journal:  Nucleic Acids Res       Date:  2012-11-24       Impact factor: 16.971

10.  Current progress of RNA aptamer-based therapeutics.

Authors:  Jiehua Zhou; Maggie L Bobbin; John C Burnett; John J Rossi
Journal:  Front Genet       Date:  2012-11-02       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.